Aurinia Sets November 4 for Earnings Reveal—Investors Eye Business Update as New Therapies Advance
Market Chameleon (Tue, 4-Nov 10:41 AM)
Aurinia Pharmaceuticals Raises 2025 Guidance After LUPKYNIS Sales Jump 27% and Net Income Surges Over 16-Fold
Market Chameleon (Tue, 4-Nov 8:43 AM)
Aurinia Addresses Retracted FDA LinkedIn Post—LUPKYNIS® Maintains Favorable Long-Term Profile Backed by AURORA Studies
Market Chameleon (Tue, 30-Sep 8:44 AM)
